The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
A brand from Opella will be part of the official NASA astronaut formulary
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
